The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Reducing mortality from 2019-nCoV: host-directed therapies should be an option.
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Most moribund COVID-19 patients are suffering from a cytokine storm.
“Most moribund COVID-19 patients are suffering from a cytokine storm (Zumla et al., 2020)”
From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Zumla et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Channappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524
Coronavirus infections and immune responses
Li, G., Fan, Y., Lai, Y., Han, T., Li, Z., Zhou, P., Pan, P., Wang, W., Hu, D., Liu, X., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25685 · Cited by 1,963
Coronaviruses — drug discovery and therapeutic options
Zumla, A. I., Chan, J. F., Azhar, E. I., Hui, D. S. C., & Yuen, K. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,711
Self-citationSevere Acute Respiratory Syndrome
Hui, D. S. C., & Zumla, A. I. (2019) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2019.07.001 · Cited by 527
Self-citationNgai, J. C. L., Ko, F. W. S., Ng, S. S., To, K., Tong, M. M. B., & Hui, D. S. C. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01720.x · Cited by 502
Self-citationThe Middle East Respiratory Syndrome (MERS)
Azhar, E. I., Hui, D. S. C., Memish, Z. A., Drosten, C., & Zumla, A. I. (2019) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2019.08.001 · Cited by 285
Self-citationBeigel, J. H., Nam, H. H., Adams, P. L., Krafft, A. E., Ince, W. L., El‐Kamary, S. S., & Sims, A. M. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2019.04.006 · Cited by 168
Batawi, S., Tarazan, N., Al-Raddadi, R. M., Qasim, E. A., Sindi, A., Johni, S. A., Al-Hameed, F. M., Arabi, Y. M., Uyeki, T. M., & Alraddadi, B. M. (2019) · Health and Quality of Life Outcomes · doi:10.1186/s12955-019-1165-2 · Cited by 162
Immune therapy in sepsis: Are we ready to try again?
Davies, R., O'Dea, K. P., & Gordon, A. C. (2018) · Journal of the Intensive Care Society · doi:10.1177/1751143718765407 · Cited by 68
Cell therapy in acute respiratory distress syndrome
Horie, S., Gonzalez, H. E., Laffey, J. G., & Masterson, C. H. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.08.28 · Cited by 59
Zumla, A. I., Azhar, E. I., Arabi, Y. M., Alotaibi, B., Rao, M., McCloskey, B., Petersen, E., & Maeurer, M. J. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.09.005 · Cited by 57
Self-citationBarnard, D. L., Wong, M., Bailey, K. W., et al. (2007) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020701800302 · Cited by 22
Clinically Relevant Immune Responses against Cytomegalovirus: Implications for Precision Medicine
Lérias, J. R., Paraschoudi, G., da Silva, I. P., Martins, J. D., de Sousa, E., Condeço, C., Figueiredo, N., Carvalho, C. T., Dodoo, E., Jäger, E., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081986 · Cited by 6
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
Zhou, Y., Fu, B., Zheng, X., Wang, D., Zhao, C., Qi, Y., Sun, R., Tian, Z., Xu, X., & Wei, H. (2020) · National Science Review · doi:10.1093/nsr/nwaa041 · Cited by 1,295
Luo, P., Qiu, L., Liu, Y., Liu, X.-L., Zheng, J.-L., Xue, H.-Y., Liu, W.-H., Liu, D., & Li, J. (2020) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-0375 · Cited by 259
Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection
Bao, L., Zhang, C., Dong, J., Zhao, L., Li, Y., & Sun, J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01840 · Cited by 207
Zumla, A., & Niederman, M. S. (2020) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000676 · Cited by 49
Self-citation
Metadata
- Authors
- Zumla, A., Hui, D. S., Azhar, E. I., Memish, Z. A., & Maeurer, M.
- Affiliations
- University College London Hospitals NHS Foundation Trust (GB)
- Chinese University of Hong Kong (HK)
- King Abdulaziz University (SA)
- Alfaisal University (SA)
- Johannes Gutenberg University Mainz (DE)
- Corresponding author
- Maeurer, Markus
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 395
- Issue
- 10224
- Pages
- e35-e36
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC7133595
- OpenAlex
- W3004743633
- Cited by
- 429
- References
- 14
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 16 · 2023: 27 · 2022: 61 · 2021: 119 · 2020: 192
- FWCI
- 13.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Lancet (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Bill and Melinda Gates Foundation
- National Institute for Health and Care Research (NF-SI-0616-10016)
- Fundação Champalimaud
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Outbreaks Research
- Keywords
- SARS-CoV-2, host-directed therapy, COVID-19 mortality, antiviral therapy, intensive care, transmission prevention, infection control
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, COVID-19 Drug Treatment, COVID-19 Serotherapy, Humans, Immunization, Passive, Pneumonia, Viral, Global Health, Coronavirus Infections, Drug Discovery, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
